ToLymph Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer (NCT06693336) | ToLymph Inc. | 2024-11-18 |
Track ToLymph Inc. automatically
Every clearance here is in the API, with alerts when new ones post.